Shionogi & Co., Ltd.

Shionogi & Co., Ltd.verified

SGIOF

Price:

$12.41

Market Cap:

$1.63T

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN1...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-02-28

Stock Exchange

PNK

Ticker

SGIOF

The PE Ratio as of November 2024 (TTM) for Shionogi & Co., Ltd. (SGIOF) is 10.43

According to Shionogi & Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 10.43. This represents a change of 137.88% compared to the average of 4.38 of the last 4 quarters.

Shionogi & Co., Ltd. (SGIOF) Historical PE Ratio (quarterly & annually)

How has SGIOF PE Ratio performed in the past?

The mean historical PE Ratio of Shionogi & Co., Ltd. over the last ten years is 6.03. The current 10.43 PE Ratio has changed 17.20% with respect to the historical average. Over the past ten years (40 quarters), SGIOF's PE Ratio was at its highest in in the June 2015 quarter at 12.11. The PE Ratio was at its lowest in in the September 2014 quarter at -74.85.

Quarterly (TTM)
Annual

Average

6.03

Median

5.42

Minimum

3.27

Maximum

10.13

Shionogi & Co., Ltd. (SGIOF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shionogi & Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 95.84%

Maximum Annual PE Ratio = 10.13

Minimum Annual Increase = -49.76%

Minimum Annual PE Ratio = 3.27

Quarterly (TTM)
Annual
YearPE RatioChange
20244.4937.45%
20233.27-49.76%
20226.5018.00%
20215.5124.42%
20204.43-16.92%
20195.331.11%
20185.27-29.19%
20177.44-6.13%
20167.93-21.74%
201510.1395.84%

Shionogi & Co., Ltd. (SGIOF) Average PE Ratio

How has SGIOF PE Ratio performed in the past?

The current PE Ratio of Shionogi & Co., Ltd. (SGIOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.75

5-year avg

4.84

10-year avg

6.03

Shionogi & Co., Ltd. (SGIOF) PE Ratio vs. Peers

How is SGIOF’s PE Ratio compared to its peers?

Shionogi & Co., Ltd.’s PE Ratio is less than Taisho Pharmaceutical Holdings Co., Ltd. (17.20), greater than Vivesto AB (-0.25), greater than Acorda Therapeutics, Inc. (-0.00), greater than Pacira BioSciences, Inc. (-8.92), greater than Shionogi & Co., Ltd. (1.97), greater than Sunshine Biopharma, Inc. (-0.71), greater than Alimera Sciences, Inc. (-20.50), greater than China SXT Pharmaceuticals, Inc. (-0.06), greater than Guardion Health Sciences, Inc. (0.65), greater than Cresco Labs Inc. (-5.67), greater than Curaleaf Holdings, Inc. (-7.18), greater than Trulieve Cannabis Corp. (-8.04), greater than Journey Medical Corporation (-6.01), greater than Aurora Cannabis Inc. (-0.43), less than Ironwood Pharmaceuticals, Inc. (21.99), greater than Assertio Holdings, Inc. (-1.31), less than Neurocrine Biosciences, Inc. (32.92), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Esperion Therapeutics, Inc. (-5.66),

Build a custom stock screener for Shionogi & Co., Ltd. (SGIOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shionogi & Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shionogi & Co., Ltd. (SGIOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shionogi & Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Shionogi & Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Shionogi & Co., Ltd. (SGIOF)?

What is the highest PE Ratio for Shionogi & Co., Ltd. (SGIOF)?

What is the 3-year average PE Ratio for Shionogi & Co., Ltd. (SGIOF)?

What is the 5-year average PE Ratio for Shionogi & Co., Ltd. (SGIOF)?

How does the current PE Ratio for Shionogi & Co., Ltd. (SGIOF) compare to its historical average?